✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹142 Cr.
P/E
37.37
About
Astonea Labs is a company that focuses on manufacturing and marketing a diverse range of pharmaceutical and cosmetic products. Their offerings include antibiotic drugs, anti-cold medications, antihist… Read more
Astonea Labs is a company that focuses on manufacturing and marketing a diverse range of pharm… Read more
Low
135
52W Range
High
140
  • Astonea Labs
  • Beta Drugs

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

2 No

Negative for this company

8 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Astonea Labs Ltd. Business

Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.

Astonea Labs major competitors are Beta Drugs.
Market Cap of Astonea Labs is ₹142 Crs.
While the median market cap of its peers are ₹1,850 Crs.

Astonea Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Astonea Labs Ltd.
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material